Organ Development: Tips from the embryonic lung
Most of our knowledge about the development of the lung comes from elegant experiments using mice (Hogan et al., 2014; Tata and Rajagopal, 2017). Despite the usefulness of mouse models, human and mouse lungs are distinct in many ways – including their size, the distribution of cell types, and the time they take to develop (Morrisey and Hogan, 2010; Wansleeben et al., 2013). Now, in eLife, Emma Rawlins and colleagues – including Marko Nikolić as first author – report that mouse and human embryonic lungs also express the same transcription factors in different patterns during development (Nikolić et al., 2017).
In both humans and mice, the lungs originate from a groove and a bud. The laryngotracheal groove becomes the future larynx and trachea, while the bud divides to become the origin of most of the branching airways and the gas-exchanging alveoli. Both bud and groove emerge from the primitive embryonic gut tube, whose epithelial layer is referred to as the embryonic anterior foregut endoderm (Figure 1A) since it originates from one of the three definitive germ layers of the embryo: the endoderm. As the embryonic lung develops, the epithelial cells at the tip of the embryonic lung proliferate most rapidly, dividing over and over to ultimately generate the beautiful branching structure of the adult organ.
Many groups in the last decade have created in vitro models to study human embryonic lung development and lung disease. Early studies focused on the stepwise differentiation of induced pluripotent stem cells (iPSCs): iPSCs were first differentiated into endoderm cells and then into the lung progenitor cells that give rise to the various different epithelial cell types of the mature airway and the alveoli (Figure 1B; McCauley et al., 2017; Snoeck, 2015). Other approaches have focused on generating an expandable source of adult airway and alveolar cells directly from adult tissues (Figure 1C; Gotoh et al., 2014; Mou et al., 2016).
In humans, for obvious reasons, it has been impossible to dissect the mechanisms that underlie how lungs and other organs develop in embryos. However, we know that in mice, the transcription factor Sox2 is essential for the initiation of lung development from the gut tube, and is later expressed exclusively in the epithelial cells of the ‘stalk’ that in turn give rise to the epithelium of the airway. By contrast, tip epithelial cells express a related transcription factor, Sox9, that is necessary for the maintenance of tip cells themselves (Hogan et al., 2014; Rockich et al., 2013).
By generating an alternate and renewable source of progenitor cells from the human embryonic lung, Nikolić et al. – who are based at the University of Cambridge and University College London – now demonstrate that, unlike in the mouse, human embryonic lung tip cells produce both SOX2 and SOX9. After dissecting human embryonic tips and stalks, global gene expression analysis of the epithelium was used to identify genes specific to each cell type. By determining which growth factor-related genes were present in each of these cells, Nikolić et al. fashioned a chemically defined medium to grow tip cells as organoids. They were further able to expand, freeze and differentiate these tip-derived cells (Figure 1D).
Interestingly, the human stalk epithelial cells that produced SOX2 but did not produce SOX9 showed remarkable plasticity, and were able to give rise to “SOX2+SOX9+” tip progenitor cells. This plasticity harkens back to a classical finding from experiments performed on mice, in which tip mesenchyme cells (these are cells adjacent to the tip epithelial cells that presumably serve as a source of the growth factors that are necessary to maintain the epithelial tip cells) were grafted onto the tracheal epithelium. This grafting resulted in the formation of buds on the trachea which then started branching (Alescio and Cassini, 1962) and this phenomenon was later shown to reflect the conversion of Sox2+ tracheal epithelial cells into Sox9+ bud cells (Hogan et al., 2014). This, however, only occurred during the very early stages of lung development. Perhaps, under the right conditions, early and late stage mouse stalk cells could exhibit plasticity that mirrors the findings of Nikolić et al. in the human case, but perhaps not.
Notably, the cultured human SOX2+SOX9+ tip cells differentiate into both airway and alveolar cells when grown in vitro or in mice. Whether the differentiated cells fully mature and become fully functional remains to be seen, but the results are promising.
The hitherto unknown facets of human embryonic lung development that Nikolić et al. reveal can now be mechanistically scrutinized. The human SOX2+SOX9+ cells they cultured could potentially be used to model pediatric lung diseases (such as bronchopulmonary dysplasia), which are thought to originate during lung development. Indeed, because human SOX2+SOX9+ cells are derived from embryonic lungs, they are likely to more faithfully reflect the epigenetic features of the embryonic cells that contribute to pediatric lung disease than cells derived from adult lung epithelial cells or iPSCs. For example, iPSC-derived lung cells could possess abnormal epigenetic marks and/or the epigenetic and genetic state of cells derived from adult lungs may reflect environmental assaults encountered in the course of adulthood that are not relevant for fetal and postnatal lung disease. Thus the availability of embryonic lung epithelial cells is likely to open up whole new fields of important inquiry.
Induction in vitro of tracheal buds by pulmonary mesenchyme grafted on tracheal epitheliumJournal of Experimental Zoology 150:83–94.https://doi.org/10.1002/jez.1401500202
Plasticity in the lung: making and breaking cell identityDevelopment 144:755–766.https://doi.org/10.1242/dev.143784
Stem cells of the adult lung: their development and role in homeostasis, regeneration, and diseaseWiley Interdisciplinary Reviews: Developmental Biology 2:131–148.https://doi.org/10.1002/wdev.58
Article and author information
We would like to acknowledge Vladimir Vinarsky, Lujia Yang and Aleksander D Szymaniak for editing the manuscript and helpful discussions.
- Version of Record published: August 14, 2017 (version 1)
© 2017, Waghray et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
- Page views
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
- Stem Cells and Regenerative Medicine
Polycomb repressive complex (PRC) 1 regulates stem cell fate by mediating mono-ubiquitination of histone H2A at lysine 119. While canonical PRC1 is critical for hematopoietic stem and progenitor cell (HSPC) maintenance, the role of non-canonical PRC1 in hematopoiesis remains elusive. PRC1.1, a non-canonical PRC1, consists of PCGF1, RING1B, KDM2B, and BCOR. We recently showed that PRC1.1 insufficiency induced by the loss of PCGF1 or BCOR causes myeloid-biased hematopoiesis and promotes transformation of hematopoietic cells in mice. Here we show that PRC1.1 serves as an epigenetic switch that coordinates homeostatic and emergency hematopoiesis. PRC1.1 maintains balanced output of steady-state hematopoiesis by restricting C/EBPa-dependent precocious myeloid differentiation of HSPCs and the HOXA9- and β-catenin-driven self-renewing network in myeloid progenitors. Upon regeneration, PRC1.1 is transiently inhibited to facilitate formation of granulocyte-macrophage progenitor (GMP) clusters, thereby promoting emergency myelopoiesis. Moreover, constitutive inactivation of PRC1.1 results in unchecked expansion of GMPs and eventual transformation. Collectively, our results define PRC1.1 as a novel critical regulator of emergency myelopoiesis, dysregulation of which leads to myeloid transformation.
- Developmental Biology
- Stem Cells and Regenerative Medicine
Cell-free DNA (cfDNA) present in the bloodstream or other bodily fluids holds potential as a non-invasive diagnostic for early disease detection. However, it remains unclear what cfDNA markers might be produced in response to specific tissue-level events. Organoid systems present a tractable and efficient method for screening cfDNA markers. However, research investigating the release of cfDNA from organoids is limited. Here, we present a scalable method for high-throughput screening of cfDNA from cardiac organoids. We demonstrate that cfDNA is recoverable from cardiac organoids, and that cfDNA release is highest early in differentiation. Intriguingly, we observed that the fraction of cell-free mitochondrial DNA appeared to decrease as the organoids developed, suggesting a possible signature of cardiac organoid maturation, or other cardiac growth-related tissue-level events. We also observe alterations in the prevalence of specific genomic regions in cardiac organoid-derived cfDNA at different timepoints during growth. In addition, we identify cfDNA markers that were increased upon addition of cardiotoxic drugs, prior to the onset of tissue demise. Together, these results indicate that cardiac organoids may be a useful system towards the identification of candidate predictive cfDNA markers of cardiac tissue development and demise.